Physician

Clayton Greer Scanlon, MD

According to 2025 Medicare claims, Clayton Scanlon, MD (NPI: 1073778460) practices ophthalmology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF ST LOUIS, INC (NPI: 1750581666) and primary practice location at 63376-1667.

Scanlon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 536 traditional Medicare patients, billed 26,610 HCPCS/CPT codes, and received $2,014,509 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 244 prescription claims across 92 beneficiaries totaling $11,361 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 31 records totaling $1,039. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $736,893 to $2,014,509. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $9,733 to $11,361. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.0M2015 Medicare payment: $736,893 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $865,771 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,181,732 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,165,599 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,424,846 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,203,841 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,175,640 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,082,828 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,165,229 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,014,509 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154786,670$736,893
20165997,277$865,771
20176148,817$1,181,732
20186398,999$1,165,599
201969110,898$1,424,846
20205777,746$1,203,841
20215397,495$1,175,640
20225277,134$1,082,828
202355913,813$1,165,229
202453626,610$2,014,509

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$23K2015 Drug cost: $9,733 (USD; Tot_Drug_Cst)2016 Drug cost: $8,041 (USD; Tot_Drug_Cst)2017 Drug cost: $9,291 (USD; Tot_Drug_Cst)2018 Drug cost: $12,533 (USD; Tot_Drug_Cst)2019 Drug cost: $16,609 (USD; Tot_Drug_Cst)2020 Drug cost: $22,741 (USD; Tot_Drug_Cst)2021 Drug cost: $22,129 (USD; Tot_Drug_Cst)2022 Drug cost: $14,435 (USD; Tot_Drug_Cst)2023 Drug cost: $17,466 (USD; Tot_Drug_Cst)2024 Drug cost: $11,361 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201564169$9,733
201657157$8,041
201767186$9,291
201884234$12,533
201989284$16,609
2020106319$22,741
2021110286$22,129
202292226$14,435
2023116298$17,466
202492244$11,361

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system371462$91
67028Injection of drug into eye2051,172$91
92012Established patient problem focused exam of visual system267835$63
92134Imaging of retina5241,655$30
92201Extended exam of the back part of the eye with retinal drawing373574$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium13239$2,566
Tobramycin-DexamethasoneTobramycin/Dexamethasone471,320$1,939
Prednisolone AcetatePrednisolone Acetate371,412$1,775
Ketorolac TromethamineKetorolac Tromethamine482,155$887
Brimonidine TartrateBrimonidine Tartrate191,040$807

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$1,039Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Clayton Greer Scanlon, MD?

Tedicare shows public-source Medicare data for Clayton Greer Scanlon, MD (NPI 1073778460), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Clayton Greer Scanlon, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Clayton Greer Scanlon, MD?

Clayton Greer Scanlon, MD is linked to RETINA ASSOCIATES OF ST LOUIS, INC (billing NPI 1750581666) in the available physician profile data.

Does Clayton Greer Scanlon, MD have Open Payments data?

Clayton Greer Scanlon, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.